Futura Medical (LSE:FUM) Additional Paid-In Capital : £71.07 Mil(As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Futura Medical Additional Paid-In Capital?

Futura Medical's quarterly additional paid-in capital increased from Dec. 2022 (£66.55 Mil) to Jun. 2023 (£70.93 Mil) and increased from Jun. 2023 (£70.93 Mil) to Dec. 2023 (£71.07 Mil).

Futura Medical's annual additional paid-in capital increased from Dec. 2021 (£66.38 Mil) to Dec. 2022 (£66.55 Mil) and increased from Dec. 2022 (£66.55 Mil) to Dec. 2023 (£71.07 Mil).

Futura Medical Additional Paid-In Capital Historical Data

The historical data trend for Futura Medical's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Futura Medical Additional Paid-In Capital Chart

Futura Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

50.00

52.81

66.38

66.55

71.07

Futura Medical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															66.38	66.40	66.55	70.93	71.07

Futura Medical Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Futura Medical Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Futura Medical's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Futura Medical (LSE:FUM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (LSE:FUM) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

FAMDF:USA GYX:Germany

Address

40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG

Website

https://www.futuramedical.com

Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief.

Futura Medical (LSE:FUM) Headlines

No Headlines